RV3 Rotavirus Vaccine: A Human Neonatal Rotavirus Vaccine For The Asia-Pacific Region
Funder
National Health and Medical Research Council
Funding Amount
$2,264,330.00
Summary
Rotavirus infection is the leading cause of severe dehydrating gastroenteritis responsible for ~600,000 deaths per year in children <5 years of age worldwide. In this proposal we outline plans for the development of a human neonatal rotavirus vaccine in Indonesia. The goal is a safe and effective rotavirus vaccine affordable for children within the Asia-Pacific region and worldwide.
RV3 Rotavirus Vaccine: Developing A Neonatal Rotavirus Vaccine Formulation For The Global Community
Funder
National Health and Medical Research Council
Funding Amount
$135,075.00
Summary
Rotavirus infection is the leading cause of severe dehydrating gastroenteritis responsible for approximately 600,000 deaths per year in children under 5 years of age worldwide. There is a commercial and public health opportunity to develop a new rotavirus vaccine that can be given at birth. By modifying the way the vaccine is made we hope that it will be more acceptable and easily delivered to children in remote communities and developing countries without the need for refrigeration.